中国药物警戒
中國藥物警戒
중국약물경계
CHINESE JOURNAL OF PHARMACOVIGILANCE
2015年
5期
311-313,315
,共4页
儿童用药%风险因素%专家调查
兒童用藥%風險因素%專傢調查
인동용약%풍험인소%전가조사
medication for children%risk factors%expert investigation
目的:通过对儿童用药风险因素的识别、梳理和评估,提出相应的应对措施来保障儿童用药安全。方法运用文献研究法,以鱼骨图法梳理儿童用药风险因素,以专家意见法咨询专家意见,完善风险因素,并请专家打分,以层次分析法对打分结果进行分析,得出重要程度较高的风险因素,据此提出应对策略。结果和结论医师诊断和患儿用药这两个环节的风险因素相对较多,医师处方时剂量单位、零或小数点错误,护士施药时未认真核对患儿信息,医师不熟悉儿童生理病理特点,医师忽视患儿疾病史和过敏史,医师处方时书写相似药品的名称这5个风险因素位于前5位。应通过风险沟通、培训和继续教育、建立备忘与考核系统等措施来保障儿童用药安全。
目的:通過對兒童用藥風險因素的識彆、梳理和評估,提齣相應的應對措施來保障兒童用藥安全。方法運用文獻研究法,以魚骨圖法梳理兒童用藥風險因素,以專傢意見法咨詢專傢意見,完善風險因素,併請專傢打分,以層次分析法對打分結果進行分析,得齣重要程度較高的風險因素,據此提齣應對策略。結果和結論醫師診斷和患兒用藥這兩箇環節的風險因素相對較多,醫師處方時劑量單位、零或小數點錯誤,護士施藥時未認真覈對患兒信息,醫師不熟悉兒童生理病理特點,醫師忽視患兒疾病史和過敏史,醫師處方時書寫相似藥品的名稱這5箇風險因素位于前5位。應通過風險溝通、培訓和繼續教育、建立備忘與攷覈繫統等措施來保障兒童用藥安全。
목적:통과대인동용약풍험인소적식별、소리화평고,제출상응적응대조시래보장인동용약안전。방법운용문헌연구법,이어골도법소리인동용약풍험인소,이전가의견법자순전가의견,완선풍험인소,병청전가타분,이층차분석법대타분결과진행분석,득출중요정도교고적풍험인소,거차제출응대책략。결과화결론의사진단화환인용약저량개배절적풍험인소상대교다,의사처방시제량단위、령혹소수점착오,호사시약시미인진핵대환인신식,의사불숙실인동생리병리특점,의사홀시환인질병사화과민사,의사처방시서사상사약품적명칭저5개풍험인소위우전5위。응통과풍험구통、배훈화계속교육、건립비망여고핵계통등조시래보장인동용약안전。
Objective Through identification, carding and evaluation of the risk factors of medication for children, to put forward the corresponding measures to ensure children's medication safety. Methods Using fishbone diagram method, child risk factors were combed, and then perfected by the method of expert advice consulting. According to expert scoring, the risk factors which are of high importance were concluded by using analytic hierarchy process(AHP) to analyze the result of the score. On the basis of these researches, coping strategies were put forward. Results and Conclusion The risk factors in the two links-physician diagnosis and medication of children are relatively more. The top five important risk factors are as follows: the dosage unit or zero or decimal point is incorrect when doctors prescribe, nurses don't check the information of the children carefully when applying medicine, doctors are unfamiliar with children's physiological and pathological characteristics, doctors ignore the history of disease and allergy in children, and doctors write the name of the similar drug when prescribing. We need to use the following measures to ensure the safety of children's drugs: risk communication, training and continuing education, establishing the memo and the appraisal system, etc.